All posts by imreal

Datex Releases Guide “How to Use a Leading Edge WMS to Gain a Competitive Edge in Volatile Times”


Datex free guide on WMS

Datex free guide

Software developer Datex recently introduced a free guide to help companies not simply survive but thrive in volatile economic times. The guide introduces the survey of 3,900 respondents conducted by Bain & Company to develop an understanding of how businesses fared during and after an economic recession based on the company’s reaction and preparedness.

The survey determined that companies that prepared in advance for an economic downturn were better positioned to gain market share and expedite growth and profitability. Investing in new technology such as a cutting-edge warehouse management system is one accepted strategy. Advance preparation and leveraging new IT capabilities can help supply chain businesses by avoiding the need to react quickly in a crisis, providing more and often better quality data for action and decision making as well as more effective tools for managing operations.

The guide also examines how relying on outdated technology can hamper a company’s ability to compete and win business. Companies still using outdated legacy warehouse management systems report inability to keep pace with competitors. Leveraging a leading-edge WMS can provide distinct advantages and help supply chain companies save on time, money and labor. The savings, increased productivity and efficiency can help make warehouse and 3PL operators win and retain business.

Share article on social media or email:

NeoTract Designates Dr. Cameron Jirschele as UroLift® Center of Excellence


News Image

“Dr. Cameron Jirschele has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Cameron Jirschele D.O., DuPage Medical Group in Chicago, IL has been designated as a UroLift® Center of Excellence. The designation recognizes that Jirschele has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Cameron Jirschele has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Serafini Law Office, LLC, announces launch of new RSerafiniLaw.com website


The Sherlock Holmes of White-Collar Criminal Law

Richard A. Serafini, Esq.

The new website does a great job illustrating my expertise in the criminal justice and civil enforcement systems with explanations of the law and is reflective of my creative strategies and procedures in protecting one’s rights.

Serafini Law Office, LLC, a Fort Lauderdale, Florida, law firm specializing in representing those who have been accused of white collar federal or state crimes or those who seek representation before governmental and self-regulatory bodies such as the Securities and Exchange Commission has launched a new website at RSerafiniLaw.com.

“The new website paints a clear picture of what I do,” said Richard A. Serafini, Esq. “By breaking down the website into the two major categories – Regulatory Law and Criminal Law – it details all the areas of law that comprise our practice.”

Dubbed “The Sherlock Holmes of White-Collar Criminal Law” by Law.com, Serafini is a former federal prosecutor who spent 10 years as a senior prosecutor at the United States Department of Justice. He was a fraud and organized crime prosecutor, serving in both the Fraud Section and as a Strike Force attorney in the Organized Crime and Racketeering Section of Justice in Washington, DC. In these positions, Serafini represented the United States in the largest and most complex cases in federal courts throughout the country.

Before joining the DOJ Serafini served as a supervisor in the New York office of the Securities and Exchange Commission, where he supervised attorneys assigned to two branches of enforcement. As the new website illustrates, Serafini now represents those who might be under scrutiny by the very offices he served or supervised.

“It helps my clients to know that my extensive background within these organizations gives them an advantage they would not otherwise have,” Serafini added. “I think the new Website does an excellent job of showing that experience and how advantageous it is for my clients that I understand the nuances of these organizations and the strategies they use in their prosecutions and investigations.”

RSerafiniLaw.com highlights areas of Criminal Law on which Serafini focuses. They range from White Collar Crime and RICO/Racketeering to Money Laundering and Securities Fraud. Each section gives a detailed explanation of the potential offenses and the likely ramifications flowing from those charges.

In addition to the various pages that focus on such topics as Drug Crimes, Computer Crimes and Business Crimes, the new website also features an FAQ, Case Studies showing examples of cases that Serafini participated in as a defense attorney, prosecutor, or representative before a regulatory board, a press kit for those members of the press who wish to interview Serafini, videos of his previous television appearances on networks like CNN and MSNBC, and a monthly blog in which the former government representative – thoroughly accomplished in all aspects of federal practice and trial work – provides a unique perspective on such topical discussions as “The Reach of Federal Conspiracy Laws,” “Ponzi Schemes,” and “Federal Sentencing Guidelines.”

The blog postings are indicative of Serafini’s vast experience practicing before the federal courts of the United States as he has handled federal court cases in Florida, New York, the District of Columbia, Georgia, North Carolina, Virginia, Oklahoma, Texas, Utah, Nevada, and California. He has also handled a select number of complex state cases and has represented clients before administrative agencies such as the SEC and before securities and industry arbitration panels.

Serafini has 40 years of experience practicing law encompassing both private practice and public representation. He has been in the private practice of law in South Florida since 2001. After spending 11 years with large firms, in 2012 Serafini began Serafini Law Office, LLC. Before moving into private practice, he served as a senior litigator in the Criminal Division of the DOJ where he specialized in fraud and organized crime prosecution.

“The new website does a great job illustrating my expertise in the criminal justice and civil enforcement systems with explanations of the law and is reflective of my creative strategies and procedures in protecting one’s rights,” said Serafini.

“I’d like to think that once a potential client reads the information on the website that person knows having me representing him or her provides an advantage against the government’s or self-regulatory body’s unlimited resources.”

To learn more about the services provided by Serafini Law Office, LLC, and Richard A. Serafini, Esq., visit the new website at http://www.RSerafiniLaw.com

Share article on social media or email:

Aries Building Systems Response to the COVID – 19 Pandemic


A 3D rendering of a white ADA- compliant modular office with maroon trimming presented on a subtle American flag backdrop and the official Aries ram head logo on top.

Modular building leader Aries Building Systems responds quickly to the COVID – 19 Pandemic

“Our goal is to continue to provide quality services during this time ensuring safety and business continuity. We understand that response time is vital and know that our modular space solutions can greatly assist during this crisis.” – Katie Roman, Vice President at Aries

Aries Building Systems, LLC, specializing in commercial modular construction is open and fully operational, supporting local, state and federal response to the COVID-19 pandemic. Aries is the largest turnkey modular general contractor in North America with manufacturing facilities located in Troy, Texas and Perris, California. Aries has deployed modular units and continues to work with agencies providing space solutions during this unprecedented time.

Aries meets customer needs and expectations through our state-of-the-art fleet, in-depth client consultation, value proposition, safety record, knowledge, and experience in the industry. With over 150,000 units totaling over $400 M in space solutions, Aries has buildings for immediate delivery to service the medical/healthcare sectors, commercial office space requirements, and any housing demands during this time.

Katie Roman, Vice President at Aries stated, “Our customer is at the core of everything we do, and in light of the World Health Organization declaring COVID-19 a pandemic, our top priority is keeping our customers, staff, and communities safe as we continue to closely monitor the situation. Aries has activated our protocol plan, and we will remain steadfast in our attention to the evolving circumstances and respond accordingly. Our goal is to continue to provide quality services during this time ensuring safety and business continuity. We understand that response time is vital and know that our modular space solutions can greatly assist during this crisis.”

Aries has added an “emergency building response” page to their website, allowing users to receive quotes quickly. In addition, they are encouraging individuals to visit their existing online inventory page, where users have the option to view current units ready for immediate deployment. customize existing buildings to meet their needs. “Anything we can do to make things faster,” adds Roman, “we are doing and will continue to do.”

About Aries Building Systems, LLC

Aries Building Systems is a privately owned company headquartered in Arlington, Virginia. Aries specializes in commercial modular construction, full turnkey workforce housing construction and financing with a track record of delivered success on some of the most demanding projects. Aries has an extensive network across North America providing modular space solutions for the medical, education, government, construction, commercial, and oil/gas sectors.

Share article on social media or email:

PathSensors, Inc. Announced the Development of a SARS-CoV-2 Biosensor


“We expect this new SARS-CoV-2 assay to dramatically expand the tools available to public health agencies fighting this pandemic,” said Ted Olsen, PathSensors’ President.

PathSensors Inc, a Baltimore biotechnology company, announced today that they are developing a CANARY ™ biosensor to detect the Novel SARS Coronavirus (SARS-CoV-2), the causal agent for the coronavirus disease COVID–19. The biosensor will be available for research purposes in May 2020 and validation data on the new SARS-CoV-2 product will be available June 2020.

CANARY ™ technology provides a unique opportunity to reduce the impending public health impact of COVID-19 with rapid results and high specificity. The initial application for this PathSensors product will be for testing of environmental swabs and air monitoring in sensitive spaces such as hospitals, offices, food services, etc. PathSensors will continue to advance the assay’s capabilities as the novel virus is further characterized. As the SARS-CoV-2 biosensor is commercialized, PathSensors expects new uses to emerge, such as rapid specimen screening.

Third-party laboratory validations have demonstrated that commercially available CANARY ™ products are highly sensitive and specific. PathSensors offers three instrumentation platforms that are easy to use and typically generate test results in less than 5 minutes. PathSensors expects the SARS-CoV-2 product to be a valuable tool for fighting the spread of COVID-19.

An expert in virology and biological threats, Dr. David Hodge was involved in commissioning and overseeing a third-party evaluation of CANARY ™ technology while working at the Department of Homeland Security as the Senior Program Manager for Basic Research and Assay Development. “Our evaluation of CANARY™ technology resulted in promising sensitivity of detection data,” said Dr. Hodge, PathSensors’ Scientific Advisor. “A SARS-CoV-2 assay would be a powerful solution to a critical problem.”

“PathSensors has a long history of manufacturing rapid and highly sensitive detection kits for dangerous biologic agents such as anthrax, orthopox, ricin, listeria, and many others. We expect this new SARS-CoV-2 assay to dramatically expand the tools available to public health agencies fighting this pandemic” said Ted Olsen, PathSensors’ President.

About COVID-19

A novel coronavirus was discovered in late 2019 in China before spreading around the world. The disease, COVID-19, causes severe pneumonia-like symptoms and can be spread via human-to-human transmission prior to any symptoms. Coronaviruses are a family of viruses that cause diseases including Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). There is still much to learn about the novel coronavirus and the impacts of COVID-19 on global health.

About CANARY Technology

CANARY ™ is a biosensor technology that delivers extremely rapid detection of pathogens with high sensitivity and specificity. Originally developed by scientists at MIT–Lincoln Laboratory to combat bioterrorism threats, CANARY ™ technology has been licensed and commercialized by PathSensors, Inc.

About PathSensors, Inc.

PathSensors is a leading environmental testing company, built on CANARY ™ technology which is exclusively licensed from MIT-Lincoln Laboratory. CANARY ™ offers cutting-edge pathogen detection capabilities to a variety of industries including food safety, agriculture, and bioterrorism. The company’s mission is to make the world a safer place by detecting pathogens that can cause sickness or worse while creating high technology jobs in the state of Maryland.

Author:

Simone Stanley

Business Development Associate

(443) 877-4015

sstanley@pathsensors.com

Contact:

Joe Kennedy

Sales Manager

(443) 887-4005

jkennedy@pathsensors.com

Share article on social media or email:

Otus Launches Free eLearning Academy to Support K-12 Students


There is clearly a monumental shift happening in K-12 education right now.

Otus, a fast-growing K-12 edtech company that provides the award winning Otus Student Performance Platform, today announced the launch of the Otus eLearning Academy, a free K-12 virtual school with a variety of courses led by highly experienced certified teachers employed by Otus.

With millions of students being forced to learn from home due to school closures resulting from the COVID-19 pandemic, families are struggling with ways to ensure that their children continue learning while K-12 school systems shift to becoming remote learning organizations.

“While Otus, like many edtech companies, is offering our software to school districts for free during this pandemic, we knew we could do more.” said Andy Bluhm, CEO of Otus and a Chicago investor and philanthropist. “We not only have an amazing platform designed to accommodate eLearning, but we also employ highly qualified teachers who have created engaging eLearning lessons that will include teacher feedback and engagement allowing students to continue their education even when they are not at their school.”

The Otus eLearning Academy is open to all K-12 students anywhere in the world. Initial course offerings include Language Arts, Math, STEM, Fine Arts, PE, Coding, Humanities, and more. In the coming weeks, additional courses will be offered for English Language Learners.

“I am really excited to be leading the Otus eLearning Academy and whether it is the primary way a student learns while out of school or if it is a supplement to their school’s eLearning plan, we want to help,” said Dr. Phil Collins, Chief Product Officer of Otus and a former Superintendent of Schools in the Chicago area. “There is clearly a monumental shift happening in K-12 education right now. If Otus is able to innovate the ways in which we support students and families during a time like this, it is only going to make us a better organization.”

To register for the Otus eLearning Academy, visit https://otus.com/learn

About Otus

The Otus platform is used by over a million users throughout the United States to provide all K-12 stakeholders with a single platform for their learning, classroom, assessment, and data management needs. Otus was recently named a Top 100 Places to Work by Built in Chicago and has received several edtech awards. Otus is based in Chicago’s popular West Loop neighborhood.

Share article on social media or email:

Freestanding ERs Ask State of Texas to Waive Restrictions, Increase Capacity to Treat Coronavirus Pandemic


Headshot of Rhonda Sandel, CEO of Texas Emergency Care Center

Rhonda Sandel, CEO of Texas Emergency Care Center

Across the state of Texas alone, there are more than 1,550 beds in 200 freestanding emergency centers. I ask that the state enable this large healthcare resource to relieve the burden on hospitals.

As coronavirus spreads throughout Texas, particularly in large urban areas like Austin, Dallas and Houston, Rhonda Sandel, CEO of Texas Emergency Care Center, founding member and immediate-past president of the Texas Association of Freestanding Emergency Centers (TAFEC), and the National Association of Freestanding Emergency Centers (NAFEC), commends Governor Abbott for his response to the pandemic and recommends that the state look to freestanding emergency centers statewide as part of the solution. Freestanding emergency centers can increase the capacity of the healthcare system to test for coronavirus and treat the outbreak, including beds, pharmacies, supplies, personal protective equipment (PPE), ventilators and trained and experienced emergency medicine physicians and staff capable of treating all urgent and emergent medical conditions.

“Across the state of Texas alone, there are more than 1,550 beds in 200 freestanding emergency centers. I ask that the state enable this large healthcare resource to relieve the burden on hospitals,” said Sandel. “There are freestanding ERs in small rural towns and rural counties as well as large, urban areas. Our ER doctors and staff can provide much needed support in the large cities, which will most likely be hit the hardest with COVID-19 cases, but basically, we have resources that are sitting idle because of burdensome regulations on freestanding ERs.”

As a leader in the industry, Sandel has been working with state and federal legislators for years to remove constraints which would make it possible to treat all Centers for Medicare and Medicaid Services (CMS) patients. In the face of the coronavirus pandemic, she says it is exponentially more time critical to increase access to emergency care and bed capacity.

With state waivers Governor Abbott could allow freestanding emergency rooms to:

  • Expand testing for Coronavirus and COVID-19.
  • Provide outpatient care services including radiology, imaging, laboratory testing, etc. at the non-emergency care rates.
  • Provide telemedicine regardless of whether or not the emergency physician is an in-network provider.
  • Participate in Centers for Medicare and Medicaid Services (CMS). Texas Medicaid could certify freestanding emergency centers while change is being determined at the federal level.

While officials are looking at alternative options to increase bed capacity for the hospitals, including hotels, closed hospitals and abandoned medical facilities, they should first rely on the licensed resources that are readily available in the state.

“There is no better immediate option than looking to freestanding emergency rooms during this time. During Hurricane Harvey, many facilities in Houston and across the state stepped up when hospitals were flooded or could not be reached. All facilities across the state are able to do this and I urge Governor Abbott to look to us now,” Sandel said.

Freestanding emergency care centers are licensed as emergency centers by the state of Texas, which means they are staffed by physicians who are trained, experienced, and/or board certified in emergency medicine, employ nurses and staff that are emergency-medicine trained, and have the same diagnostic testing, laboratory services, resources, and equipment including ventilators, as a hospital emergency department.

“I have personally been working closely with Houston-area hospital systems in order to increase their capacity to treat COVID-19 and hope this will be made possible statewide. Freestanding emergency rooms have the doctors, nurses, staff, equipment, supplies, and facilities to be part of the solution and we are ready to help,” she said.

About Rhonda Sandel, RN, Texas Emergency Care Center CEO

An active voice and industry advocate, Rhonda Sandel formed Sandel Healthcare Consulting in 2014 to share her knowledge, experience and expertise in the healthcare industry. As an industry leader and expert in healthcare operations and management, Rhonda is sought out by healthcare professionals and legal groups for consulting on practice development and management, ambulatory surgery centers, emergency room operations and management, and legal consulting. A known industry leader, Rhonda is frequently called upon to testify regarding regulatory issues.

Rhonda began her career in the healthcare industry over 25 years ago as a registered nurse before starting Sandel Legal Nurse Consultants in 2001. While consulting, she met the physicians that ultimately founded Texas Emergency Care Center, joining their team as CEO.

As part of their vibrant practice, Texas Emergency Care Center began their own internal revenue cycle efforts. It wasn’t long before their success brought requests to take on external clients and Gryphon Healthcare was born.

In addition to her role at Gryphon Healthcare, Rhonda is an active, founding member and Immediate-Past President of the Texas Association for Freestanding Emergency Centers (TAFEC) and National Association of Freestanding Emergency Centers (NAFEC).

Rhonda has been featured in several prime-time news stories as well as an interview on Fox Business and an article featured in USA today. Rhonda was recently named as one of the most admired CEOs in Houston by The Houston Business Journal alongside 41 other for-profit CEOs.

About Texas Emergency Care Centers

One of the first freestanding emergency rooms in Texas, Texas Emergency Care Centers opened its doors in 2006 with the mission to provide the highest level of emergency medical care to each patient we treat. The physicians at Texas Emergency Care Center are residency-trained and board certified or board eligible in Emergency Medicine. But providing the best care isn’t just about the way we treat symptoms – it’s about how we treat the patient. At the core of this mission are the values that we live by, every day. Our 24/7 emergency rooms are located in the Greater Houston areas and are Joint Commission Accredited. For more information or to contact Texas Emergency Care Centers, visit http://www.txercare.com and follow @TxErCareHouston on Twitter and @TxERCare on Facebook.

Share article on social media or email:

How will faith in God save a woman’s second chance at love when she is tested by ‘A Major Hurdle’


News Image

Being the optimist that she is, Patricia Sims believes in romance and in positive outcomes regardless of the difficulties a person may encounter. This, partnered with her overactive imagination and passion for writing, became her fuel to create her first published book, “A Major Hurdle” (published by AuthorHouse).

Sims’ book is a thriller-romance fiction that introduces readers to Catherine Adams, a mother of three who has struggled with grief and is given a second chance at love. She meets new love through the character of Philip Cagney, but is hurdled by doubt and fear after the negative, unfortunate occurrences the day after meeting him. Catherine and Philip are faced with mysterious circumstances that threaten to destroy them.

How will God — and their faith upon him — help them withstand and overcome their trials? Will Catherine be able to accept and enjoy this second chance at love? For more details on the book, please visit https://www.authorhouse.com/en/bookstore/bookdetails/808178-a-major-hurdle.

“The book is a roller coaster of emotions that will touch your heart and remind all of us that love finds a way,” Sims describes. “[It is] a must read for anyone who has lost faith in love and maybe have lost faith in God.” Through “A Major Hurdle,” she hopes to remind readers that God’s love is more powerful than anything and that faith can help them overcome their struggles and trials in life.

A passage in the book reads:

Two days after returning home, she received a letter from Philip. Nervously, she tore open the envelope and with a little cry of anguish, dropped it to the floor. It was over. The very thing she had feared had finally happened. She had blown all chances with him because she was too stupid to recognize a good thing, too mixed up in the head to reach for this one last chance she had been offered. Now it was over and her life felt like it was also over.

“A Major Hurdle”

By Patricia Sims

Softcover | 5×8 in | 182 pages | ISBN 9781728343945

E-Book | 182 pages | ISBN 9781728343938

Available at Amazon and Barnes & Noble

About the Author

Patricia Sims is a retired educator and loves writing poems, songs, short stories and novels. She feels that God’s hand is leading her in everything that she does. She is married to Johnny Sims, her high school sweetheart and they enjoy their three children, Vickie, Stacey and Jon Isaac, and four grandchildren. Sims and her husband released their first gospel CD in January 2019.

AuthorHouse, an Author Solutions, Inc. self-publishing imprint, is a leading provider of book publishing, marketing, and bookselling services for authors around the globe and offers the industry’s only suite of Hollywood book-to-film services. Committed to providing the highest level of customer service, AuthorHouse assigns each author personal publishing and marketing consultants who provide guidance throughout the process. Headquartered in Bloomington, Indiana, AuthorHouse celebrates over 23 years of service to authors. For more information or to publish a book visit authorhouse.com or call 1-888-519-5121.

Share article on social media or email:

A Guide to the New EU MDR and Revised ISO 14155 Management Report


WCG CenterWatch

WCG CenterWatch

The world of clinical trials is changing rapidly, with the EU MDR’s new and more complex rules and the forthcoming ISO/DIS 14155:2018 updates.

The Medical Device Trials in the EU: A Guide to the New EU MDR and Revised ISO 14155 management report provides insight into the EU MDR’s extensive requirements for documenting, conducting and reporting clinical trials, including which devices are exempt. Manufacturers of non-exempt devices must set up a clinical trials program using both EU MDR and ISO/DIS 14155:2018.

Expert Dan O’Leary, President of Ombu Enterprises, LLC, explains the EU MDR’s extensive requirements and concepts in his comprehensive, easy-to-understand approach:


  • Understand the role of clinical trials in the EU MDR
  • Learn which device types require clinical trials
  • Determine whether an exemption applies to your device
  • Learn how to integrate the EU MDR and ISO/DIS 14155:2018
  • Understand the role of the Notified Body and Competent Authority
  • Grasp the format and contents of the application, investigator’s brochure and clinical trials plan
  • Determine informed consent requirements

Make sure one fully understands the EU MDR’s and ISO/DIS 14155:2018’s clinical trials requirements — how they work together and how to make them work.

Management Report Details:

Medical Device Trials in the EU:

A Guide to the New EU MDR and Revised ISO 14155

A CenterWatch Management Report

https://www.fdanews.com/products/category/223-device-books/product/59187-medical-device-trials-in-the-eu-a-guide-to-the-new-eu-mdr-and-revised-iso-14155

Management Report PDF:

$397

Easy Ways to Order:

Online: https://www.fdanews.com/products/category/223-device-books/product/59187-medical-device-trials-in-the-eu-a-guide-to-the-new-eu-mdr-and-revised-iso-14155

By phone: 888.838.5578 or 703.538.7600

About CenterWatch:

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email:

Great Pet Care Releases COVID-19 Infographic and Pet Preparedness Tips from Veterinarians


COVID-19 and Pets Infographic

COVID-19 and Pets: Infographic

“Despite the number of humans infected with COVID-19, there have not been any cases of pets showing clinical signs of being sick from this virus.” – Dr. Sarah Wallace

With uncertainty surrounding COVID-19, pet parents all over the world have questions about how the virus will impact their four-legged family members. They’re concerned about whether pets can contract the disease, if pet food will continue to be stocked in stores, and how they can provide their pets with enrichment and keep them active at home.

GreatPetCare.com, along with its veterinary contributors, is supplying information about the steps pet owners can take to prepare and protect their pets during the pandemic.

COVID-19 and Pets: Just the Facts

“As far as we know, pets cannot contract COVID-19,” says Dr. Sarah Wallace, a veterinarian based outside of Washington, D.C. and a contributor to GreatPetCare.com. “Despite the number of humans infected with COVID-19, there have not been any cases of pets showing clinical signs of being sick from this virus.”

Wallace adds, “There have also been no positive COVID-19 tests reported from the major veterinary diagnostic laboratory, IDEXX.”

Tips for Pet Preparedness

There are some steps that pet owners can take to help keep their pets safe during this time:

Keep a supply of food and medications on hand.

“Pet owners should also consider keeping at least a month’s supply of medication and food on hand for their pets,” says Dr. Elizabeth Racine, a veterinary journalist and contributor to GreatPetCare.com. “Many veterinary clinics are now partnered with online pharmacies and pet food companies that will deliver products directly to the client. I recommend pet owners contact their veterinarian for information about signing up for these services, which will minimize trips to the store and the veterinary clinic.”

Consider telemedicine for routine veterinary appointments or questions.

“Pet parents should try and talk to their vet over the phone, as a telemedicine appointment, before scheduling an in-person visit as much as possible,” says Dr. Hanie Elfenbein, a veterinarian based in Chattanooga, Tennessee and a veterinary journalist for GreatPetCare.com. “Many minor or repeat ailments can be treated without an office visit if you have a current relationship with your veterinarian.”

Keep pets busy with interactive games and toys.

“Keep pets enriched by using puzzle toys, hiding treats around the house, or encouraging pets to ‘work for their supper by practicing tricks and obedience commands in exchange for bits of kibble,” adds Racine.

Enrich your cat’s home environment.

“Make sure cats have things to climb, scratch, and lots of space that is up high,” says Dr. Sarah Wooten, a Colorado-based veterinarian and contributor to GreatPetCare.com. “They like to watch their underlings (AKA humans) from above!”

Try to remain calm.

“Your pet likely senses your stress about the pandemic and will in turn feel stressed,” says Wallace. “Exercise, food, regularity in their daily schedules, and the love of their human should help reduce their anxiety—and yours too!”

COVID-19 and Pets Infographic

To help pet owners through this challenging time, GreatPetCare.com created and published an infographic to provide important information about COVID-19 and pets.

You can view the full infographic and share it on your website by clicking here.

About Great Pet Care

Great Pet Care, a division of Metamorphosis Partners, is an online publication that provides pet parents with practical, medically-sound pet health information, delivered with clarity and kindness. We provide pet parents with the most up-to-date and accurate articles and guides by working with a team of board-certified veterinarians, licensed veterinary technicians, and expert trainers.

About Metamorphosis Partners

Metamorphosis Partners is dedicated to the creation, incubation and acceleration of products and businesses in the $80+ billion pet industry focused on the consumer. In addition to Great Pet Care, our portfolio of brands includes The Anxious Pet and Muttropolis. Our highly experienced in-house management team, deep network of advisors and commitment to cultivating and partnering with entrepreneurs makes us uniquely capable of building, growing and operating innovative businesses that scale rapidly and run efficiently.

MEDIA CONTACT:

Deidre Grieves

Director of Content for GreatPetCare.com

deidre@metamorphosis.com

Share article on social media or email: